Stockscreener 앱 받기
30.50
2.96%
-0.93
시간 외 거래:
30.06
-0.44
-1.44%
전일 마감가:
$31.43
열려 있는:
$30.5
하루 거래량:
113.04K
Relative Volume:
0.39
시가총액:
$38.48M
수익:
-
순이익/손실:
$-29.80M
주가수익비율:
-25.63
EPS:
-1.19
순현금흐름:
$-25.19M
1주 성능:
+0.93%
1개월 성능:
+242.70%
6개월 성능:
+266.59%
1년 성능:
+242.70%
1일 변동 폭
$30.13
$31.30
1주일 범위
$26.09
$32.95
52주 변동 폭
$5.00
$36.76
센세이 바이오테라 Stock (SNSE) Company Profile
명칭
Sensei Biotherapeutics Inc
전화
(240) 243-8000
주소
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
30.50 | 39.65M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
센세이 바이오테라 Stock (SNSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | H.C. Wainwright | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2021-07-01 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-06-29 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-03-01 | 개시 | Berenberg | Buy |
| 2021-03-01 | 개시 | Citigroup | Buy |
| 2021-03-01 | 개시 | Oppenheimer | Outperform |
| 2021-03-01 | 개시 | Piper Sandler | Overweight |
모두보기
센세이 바이오테라 주식(SNSE)의 최신 뉴스
Fed Meeting: Whats next for CRWD stock2025 Market WrapUp & Accurate Entry/Exit Alerts - baoquankhu1.vn
Trails Edge Capital Partners, LP Acquires Shares in Sensei Bioth - GuruFocus
Revenue Check: Is Sensei Biotherapeutics Inc being accumulated by smart moneyWeekly Gains Summary & Accurate Buy Signal Notifications - baoquankhu1.vn
Sensei Biotherapeutics grants stock options to 17 new employees - Investing.com
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 25, 2026 - BioSpace
Sensei Biotherapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
SNSE (NASDAQ: SNSE) insider schedules sale of 3,374 shares; prior sale 42,594 - Stock Titan
SNSE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sensei Biotherapeutics Acquires Faeth Therapeutics and Raises US$200 Million in Private Placement - Global Legal Chronicle
Sensei Biotherapeutics Merges with Faeth Therapeutics, Secures $200M Funding - National Today
What is Sensei Biotherapeutics Inc. s revenue forecastJuly 2025 Trade Ideas & Precise Buy Zone Tips - mfd.ru
Sensei Biotherapeutics, Inc. (SNSE) Faeth Therapeutics, Inc.M&A CallSlideshow (NASDAQ:SNSE) 2026-02-20 - Seeking Alpha
Sensei Biotherapeutics (SNSE) COO and director added as SEC insider - Stock Titan
Sensei Biotherapeutics Acquires Faeth Therapeutics - Global Legal Chronicle
Sensei Biotherapeutics Closes Faeth Acquisition and Financing - The Globe and Mail
Sensei Biotherapeutics Secures Future with Faeth Therapeutics Acquisition and $200M Financing - Beijing Times
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition - MSN
Sensei Biotherapeutics Acquires Faeth Therapeutics and Secures $200 Million Funding - El-Balad.com
Sensei Biotherapeutics PIPE in Connection with its Acquisition of Faeth Therapeutics - Leerink Partners
Sensei/Faeth Merger Will Keep Both Firms’ Cancer Pipelines Active - Citeline News & Insights
Merger deal renews Faeth in Sensei; Piktor brightens, stock jumps - BioWorld MedTech
Small Cap Stocks To Add to Your WatchlistFebruary 18th - MarketBeat
Sensei Biotherapeutics Stock Soars 230% After Faeth Deal - Bitget
Why Is Sensei Biotherapeutics Stock Skyrocketing Wednesday?Sensei Biotherapeutics (NASDAQ:SNSE) - Benzinga
Sensei Biotherapeutics (SNSE) Shares Soar After $200M Acquisitio - GuruFocus
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Solve PI3K Resistance - HIT Consultant
Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug - Fierce Biotech
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Jumps 150% On Faeth Therapeutics Buyout And $200M Financing - Nasdaq
Sensei Biotherapeutics stock soars after Faeth Therapeutics acquisition By Investing.com - Investing.com Canada
Sensei Biotherapeutics stock soars after Faeth Therapeutics acquisition - Investing.com
SNSE: Acquisition and $200M financing position the combined entity as a leader in multi-node cancer therapies - TradingView
Sensei Biotherapeutics (SNSE) Acquires Faeth Therapeutics to Exp - GuruFocus
SNSE: Acquisition and $200M financing advance a novel cancer therapy toward key clinical milestones - TradingView
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - The Joplin Globe
Form 4: Donenberg Phillip B. reports acquisition/exercise transactions in SNSE - Stock Titan
SNSE Technical Analysis & ETF Price Forecast - Intellectia AI
Sensei Biotherapeutics Expands Board, Adds Finance Expertise - The Globe and Mail
What is the Moat Score of Sensei Biotherapeutics Inc.Earnings Risk Summary & Weekly High Return Stock Forecasts - mfd.ru
Sensei Biotherapeutics Charts a Strategic Pivot After Halting Lead Candidate - AD HOC NEWS
Sensei Biotherapeutics (NASDAQ: SNSE) expands board of directors to five - Stock Titan
Is Sensei Biotherapeutics Inc. stock a top performer YTDJuly 2025 WrapUp & Free Expert Approved Momentum Trade Ideas - mfd.ru
Is Sensei Biotherapeutics Inc.’s growth already priced inPortfolio Gains Report & Community Verified Swing Trade Signals - mfd.ru
Can Sensei Biotherapeutics Inc. be the next market leaderJuly 2025 Sector Moves & Weekly Setup with ROI Potential - mfd.ru
What is Sensei Biotherapeutics Incs TAM Total Addressable MarketDay Trade & Scalable Portfolio Growth Methods - baoquankhu1.vn
Market Rankings: Is Sensei Biotherapeutics Inc. a speculative investmentTrade Entry Report & Low Risk Investment Opportunities - baoquankhu1.vn
AI Stocks: What is Sensei Biotherapeutics Incs revenue forecastProfit Target & Safe Capital Allocation Plans - baoquankhu1.vn
Sensei Biotherapeutics Halts Flagship Program, Weighs Sale or Shutdown - AD HOC NEWS
Portfolio Recap: Does Sensei Biotherapeutics Inc have pricing powerDay Trade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Valuation Update: Will FG Merger II Corp Equity Right outperform its industry peersNew Guidance & Daily Technical Stock Forecast Reports - baoquankhu1.vn
센세이 바이오테라 (SNSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.69%
0.68%
자본화:
|
볼륨(24시간):